bioRxivBioengineeringPreprint
Title: Zero-shot automated insulin delivery for type 1 diabetes via dynamic physiology-aware reinforcement learning
Junyoung YooiD, Vega Pradana RachimiD, Yein Lee, Jaeyeon LeeiD, Seong-Jin ParkiD
Abstract
Insulin therapy in type 1 diabetes requires constant dose adjustment based on blood glucose, meals, physiological states, and physical activity. This demanding self-management imposes a substantial burden and increases dosing-error risk, underscoring the need for automated insulin delivery (AID) systems that reduce user intervention. However, many current systems depend on fixed, individualized parameters and may not fully adapt to rapid or unobserved physiological changes. We developed the Dynamic Physiology-Aware Reinforcement learning Controller (DPARC), a zero-shot insulin optimizer that infers latent physiological dynamics from recent continuous glucose monitoring (CGM) and insulin-delivery history without prior personalization, carbohydrate announcements, or preset subject-specific parameters. DPARC uses a rolling 24-hour CGM and insulin-history window, but closed-loop operation can begin after 1 hour of observed data by initializing unobserved history with neutral normalized padding and progressively replacing it with observations. In silico, a single frozen DPARC policy adapted within 1 hour, improved time in range compared with a total daily insulin-conditioned reinforcement learning baseline, and approached the upper-bound performance of a fully personalized model under stochastic unannounced meals with randomized timing, carbohydrate amounts, absorption variability, and meal skipping. In supervised porcine studies under unannounced meals, DPARC maintained high time in range without manual configuration, supporting large-animal feasibility while prospective human evaluation is needed before clinical efficacy can be established. Learned latent representations correlated with physiological markers including insulin sensitivity and plasma insulin concentration, supporting physiological alignment and explanatory anchors. Collectively, these findings support DPARC as a preclinical proof-of-concept zero-shot AID framework for future supervised human evaluation.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes
Yixiang Deng, Kevin Arao, … George Em Karniadakis·Smart HealthPeer-reviewed·Jan 18, 2026
- Risk-Aware Control for Insulin Delivery via Nonlinear MPC with Safety Barrier Functions and Probabilistic Learning of Uncertainties
Aliasghar Arab, Seyedreza Mohamadi, … Katsuo Kurabayashi·bioRxiv·Sep 12, 2025
- New model of glucose-insulin regulation characterizes effects of physical activity and facilitates personalized treatment evaluation in children and adults with type 1 diabetes
Julia Deichmann, Sara Bachmann, … Hans‐Michael Kaltenbach·PLoS Computational BiologyPeer-reviewed·Feb 15, 2023
- A Comprehensive Model of Glucose-Insulin Regulation Including Acute and Prolonged Effects of Physical Activity in Type 1 Diabetes
J. Deichmann, S. Bachmann, … H.-M. Kaltenbach·bioRxiv·Jun 9, 2021
- Optimizing Glycemic Control in Type 1 Diabetic Patients using a Deep Learning-Based Artificial Pancreas with a Secure Glucagon and Insulin Delivery System
- An ultra-long acting insulin enables glucose-synchronised release
Yang Zhang, Juan Zhang, … Zhen Gu·bioRxiv·Oct 12, 2025